Clovis Oncology

+$0.35 (+6.35%) Today
-$0.07 (-1.19%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CLVS and other stocks, options, and ETFs commission-free!

About CLVS

Clovis Oncology, Inc. Common Stock, also called Clovis Oncology, is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments.

CEO
Patrick J. Mahaffy
Employees
429
Headquarters
Boulder, Colorado
Founded
2009

CLVS Key Statistics

Market Cap
660.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.26M
High Today
$6.36
Low Today
$5.27
Open Price
$5.28
Volume
12.76M
52 Week High
$11.10
52 Week Low
$4.08

CLVS Earnings

-$1.89
-$1.47
-$1.06
-$0.64
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.72 per share
Actual
-$0.64 per share
Replay Earnings Call

You May Also Like

ALUS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure